Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenshuaikang is a traditional Chinese medicine (TCM) capsule developed and manufactured by Shaanxi Shanhaidan Pharmaceutical. It is specifically indicated for the treatment of neurasthenia, insomnia, and fatigue, particularly when these conditions are attributed to kidney and spleen deficiency according to TCM diagnostic criteria. The formulation is designed to tonify the kidney, strengthen the spleen, and nourish the heart to calm the spirit (Anshen). As a multi-herb preparation, it contains various phytochemicals that work synergistically to restore physiological balance and improve sleep quality and energy levels. It is an approved pharmaceutical product in China (NMPA approval number Z20025071).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shenshuaikang (Shaanxi Shanhaidan Pharmaceutical).